These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 11919460

  • 1. Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors.
    Tsatalpas P, Beuthien-Baumann B, Kropp J, Manseck A, Tiepolt C, Hakenberg OW, Burchert W, Franke WG, Wirth MP.
    Urol Int; 2002; 68(3):157-63. PubMed ID: 11919460
    [Abstract] [Full Text] [Related]

  • 2. FDG PET for detection and therapy control of metastatic germ cell tumor.
    Cremerius U, Effert PJ, Adam G, Sabri O, Zimmy M, Wagenknecht G, Jakse G, Buell U.
    J Nucl Med; 1998 May; 39(5):815-22. PubMed ID: 9591582
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
    Pfannenberg AC, Oechsle K, Kollmannsberger C, Dohmen BM, Bokemeyer C, Bares R, Vontheim R, Claussen CD.
    Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
    [Abstract] [Full Text] [Related]

  • 5. Role of 18 F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up.
    Dolci C, Ceppi L, Guerra L, Crivellaro C, Lamanna M, Adorni M, Elisei F, Bonazzi CM, Sina F, Fruscio R, Messa C.
    Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group.
    Oechsle K, Hartmann M, Brenner W, Venz S, Weissbach L, Franzius C, Kliesch S, Mueller S, Krege S, Heicappell R, Bares R, Bokemeyer C, de Wit M, German Multicenter Positron Emission Tomography Study Group.
    J Clin Oncol; 2008 Dec 20; 26(36):5930-5. PubMed ID: 19018083
    [Abstract] [Full Text] [Related]

  • 8. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours.
    Lassen U, Daugaard G, Eigtved A, Højgaard L, Damgaard K, Rørth M.
    Eur J Nucl Med Mol Imaging; 2003 Mar 20; 30(3):396-402. PubMed ID: 12634968
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
    Alongi P, Evangelista L, Caobelli F, Spallino M, Gianolli L, Midiri M, Picchio M.
    Eur J Nucl Med Mol Imaging; 2018 Jan 20; 45(1):85-94. PubMed ID: 28828589
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET.
    Bokemeyer C, Kollmannsberger C, Oechsle K, Dohmen BM, Pfannenberg A, Claussen CD, Bares R, Kanz L.
    Br J Cancer; 2002 Feb 12; 86(4):506-11. PubMed ID: 11870528
    [Abstract] [Full Text] [Related]

  • 17. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.
    Acta Gastroenterol Belg; 2007 Feb 12; 70(4):331-8. PubMed ID: 18330088
    [Abstract] [Full Text] [Related]

  • 18. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
    Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Harper PG, Huddart RA.
    Br J Cancer; 2000 Oct 12; 83(7):863-9. PubMed ID: 10970686
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single-centre experience with long-term follow up.
    Karapetis CS, Strickland AH, Yip D, Steer C, Harper PG.
    Intern Med J; 2003 Oct 12; 33(9-10):427-35. PubMed ID: 14511195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.